Dexamethasone palmitate clinical trials
A product of Dexamethasone; its studies count on that page too.
How each study uses dexamethasone palmitate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the dexamethasone palmitate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 30 Oct 1958 · DECADRON · NDA 011664 (FDA, Drugs@FDA; as Dexamethasone)
- European Union
- 16 Mar 2016 · Neofordex · EMEA/H/C/004071 (EMA; as Dexamethasone)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Dexamethasone Palmitate
- 5
Studies by the year they started
6 studies that test it; most in 2025 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 5
Beijing Tiantan Hospital (4) · Xijing Hospital (1) · Santen SAS (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Dexamethasone
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test dexamethasone palmitate.
- Nov 2026Dexamethasone Palmitate for PONV After Open SurgeryNot applicable · Beijing Tiantan Hospital
- May 2027Dexamethasone Palmitate for PONV After CraniotomyNot applicable · Beijing Tiantan Hospital
- Jun 2027Dexamethasone Palmitate for Postoperative PainNot applicable · Beijing Tiantan Hospital
Studies
Open first, then newest update. How each study uses dexamethasone palmitate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Dexamethasone Palmitate for Postoperative PainRecruitingNot applicableBeijing Tiantan HospitalNCT07341854Written as dexamethasone palmitate
- Dexamethasone Palmitate for PONV After CraniotomyRecruitingNot applicableBeijing Tiantan HospitalNCT06988124Written as Dexamethasone Palmitate
- Dexamethasone Palmitate for PONV After Open SurgeryRecruitingNot applicableBeijing Tiantan HospitalNCT06997419Written as Dexamethasone Palmitate
- PANDORA: Paravertebral AdjuNctive DexamethasOne Palmitate Reducing Chronic Pain After Caridiac SurgeryCompletedNot applicableXijing HospitalNCT05920967Written as Dexamethasone Palmitate
- Dexamethasone Palmitate for PONV After Minimally Invasive Endoscopic SurgeryCompletedNot applicableBeijing Tiantan HospitalNCT06981754Written as Dexamethasone palmitate
- Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic RetinopathyCompletedPhase 1Santen SASNCT00665106Written as NOVA63035 "Corticosteroid"
Codes
What other systems call dexamethasone palmitate · ClinicalTrials.gg INT003043
- MeSH (NLM) C035081dexamethasone 21-palmitateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 601XWN7060DEXAMETHASONE PALMITATEConfirmed FDA, NLM, Wikidata
- Wikidata Q27263139dexamethasone palmitateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C216296Dexamethasone PalmitateOne source FDA
- DrugBank DB19168One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C035081 | dexamethasone 21-palmitate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 601XWN7060 | DEXAMETHASONE PALMITATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27263139 | dexamethasone palmitate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C216296 | Dexamethasone Palmitate | One source FDA |
| DrugBank | DB19168 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.